Research links circadian rhythms to sudden cardiac death
A fundamental discovery reported in the March 1st issue of the journal Nature, uncovers the first molecular evidence linking the body's natural circadian rhythms to sudden cardiac death (SCD). Ventricular arrhythmias, or abnormal heart rhythms, are the most common cause of sudden cardiac death: the primary cause of death from heart disease. They occur most frequently in the morning waking hours, followed by a smaller peak in the evening hours. While scientists have observed this tendency for many years, prior to this breakthrough, the molecular basis for these daily patterns was unknown.
The discovery will be the first step towards new diagnostic tools and therapies to prevent or treat the occurrence of this fatal event.
The research team led by Case Western Reserve University School of Medicine discovered that a novel genetic factor, Kruppel-like Factor 15 (KLF15), links the body's natural circadian rhythm to, and regulates the heart's electrical activity. A lack or excess of KLF15, causes a loss or disruption in the heart's electrical cycle and greatly increases susceptibility to arrhythmias. A lack of KLF15 is seen in patients with heart failure, while its excess causes electrocardiography (ECG) changes such as those seen in patients with Brugada syndrome, a genetic heart rhythm disorder.
"Our study identifies a hitherto unknown mechanism for electrical instability in the heart. It provides insights into day and night variation in arrhythmia susceptibility that has been known for many years," said Darwin Jeyaraj, MD, MRCP, assistant professor of medicine at Case Western Reserve University School of Medicine, cardiologist at Harrington Heart & Vascular Institute at University Hospitals Case Medical Center, and lead author of this work.
Sudden cardiac death due to electrical instability is the leading cause of death in the United States 700-800 deaths per day. There is estimated to be about 325,000 deaths annually due to SCD in the United States, easily a leading cause of death in the U.S. SCDs accounted for 10,460 (75.4 percent) of all 13,873 cardiac disease deaths in persons aged 35-44 years old.
With this understanding, scientists can propose new patient treatments with the goal of reducing incidences of sudden cardiac death. For example, knowing that KLF15 levels are reduced in heart failure patients, medications that increase KLF15 levels, particularly at certain times of the day when sudden death is more common, could reduce the incidence of this fatal disorder.
This landmark finding proves that circadian rhythms are an important factor in sudden cardiac death. In addition, it raises the possibility that additional factors may affect the occurrence of sudden cardiac death. Further studies are needed to examine the how additional components of the biological clock can affect electrical stability in the heart.
"This it is the first time a definitive link between circadian rhythms and sudden cardiac death has been established," said Mukesh K. Jain, MD, FAHA, professor of medicine, Ellery Sedgwick Jr. Chair, and director, Case Cardiovascular Research Institute at Case Western Reserve University School of Medicine and the chief research officer, Harrington Heart & Vascular Institute at University Hospitals Case Medical Center. "We are just scratching the surface. It might be that, with further study, assessment of circadian disruption in patients with cardiovascular disease might lead us to innovative approaches to diagnosis, prognosis, and treatment. In particular, such therapies could be beneficial for patients with heart failure or hereditary mutations where nocturnal death is common."
Provided by Case Western Reserve University
- Enzyme prevents fatal heart condition associated with athletes May 25, 2011 | not rated yet | 0
- Predictors of dying suddenly versus surviving heart attack identified Jul 25, 2011 | not rated yet | 0
- Wearable defibrillator can prevent death in people with arrhythmias Nov 13, 2011 | not rated yet | 0
- Heart checks urged for athletes Oct 04, 2006 | not rated yet | 0
- Gene variant may predict sudden cardiac death risk for blacks May 11, 2011 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
The Durability of Bone: Long Falls
5 hours ago I am doing a paper on the physics in Valve's Portal and got interested in the "Long Fall Boots" that prevent any damage no matter how far you fall. I...
Is energy convertible to matter?
6 hours ago Can we convert energy to matter?
Rotating electron as a dipole is this right?
9 hours ago An electron as shown by the Stern Gerlach experiment behaves like a dipole (albeit only in one of two states). I have been trying to figure out how...
Dipole term in multipole expansion
13 hours ago Hi. I'm having some difficult in understanding something about the dipole term in a multipole expansion. Griffiths writes the expansion as a sum of...
Bubbles in a Pre-Boiling/Boiling pot of water
14 hours ago How is it that bubbles form on the bottom of a surface of a pot of boiling water? I think that there is probably an elementary answer to this...
Assumptions of Griffith's fracture theory
May 21, 2013 Any experts on Griffith's fracture theory? I am studying the subject and I am having hard time finding out if the theory is valid for all possible...
- More from Physics Forums - Classical Physics
More news stories
The Orsiro stent, which is a novel stent platform eluting sirolimus from a biodegradable polymer, demonstrated non-inferiority to the Xience Prime everolimus-eluting stent for the primary angiographic endpoint of in-stent ...
Cardiology 9 hours ago | 5 / 5 (1) | 0
One-year results from SOURCE XT – one of the largest, post-approval transcatheter aortic valve implantation (TAVI) registries to-date – reported today at EuroPCR 2013 show good clinical outcomes in routine clinical practice, ...
Cardiology 10 hours ago | not rated yet | 0
A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.
Cardiology 11 hours ago | 5 / 5 (1) | 0 |
(Medical Xpress)—In a recent subgroup analysis of the largest blood pressure treatment trial in history, University of Alabama at Birmingham (UAB) researchers found that women and men react the same to ...
Cardiology 19 hours ago | 5 / 5 (1) | 0
(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...
16 hours ago | 4.2 / 5 (5) | 0 |
(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...
13 hours ago | 4.9 / 5 (11) | 0 |
Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.
15 hours ago | 4.6 / 5 (7) | 0 |
An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.
9 hours ago | 3.7 / 5 (3) | 0
Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...
10 hours ago | 5 / 5 (4) | 0 |
Researchers at USC have found that a class of pharmaceuticals can both prevent and treat Alzheimer's Disease in mice.
13 hours ago | 5 / 5 (6) | 0 |